TODAY: Gb Sciences' Novel Plant-Inspired Pain Medications
President and Chief Science Officer Dr. Andrea Small-Howard stressed the importance of developing their innovative, plant-inspired formulations as a...
Source: globenewswire.com
Page 6 - Gb Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gb Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gb Sciences Today - Breaking & Trending Today
FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Short Interest in GB Sciences, Inc. (OTCMKTS:GBLX) Expands By 175.3%
GB Sciences, Inc. (OTCMKTS:GBLX – Get Rating) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 24,500 shares, a growth of 175.3% from the March 31st total of 8,900 shares. Based on an average daily volume of 798,300 shares, the […]
Source: etfdailynews.com
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge
LAS VEGAS, April 12, 2022 -- Gb Sciences, Inc. , a leading plant-inspired biopharmaceutical research and development company, has selected the University of Lethbridge in Canada to complete a... | April 12, 2022
Source: marketscreener.com
GB Sciences (OTCMKTS:GBLX) Stock Price Crosses Above 50 Day Moving Average of $0.03
GB Sciences, Inc. (OTCMKTS:GBLX – Get Rating) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.03 and traded as high as $0.03. GB Sciences shares last traded at $0.03, with a volume of 198,643 shares changing hands. The firm has a 50-day […]
Source: etfdailynews.com